ACADIA Pharmaceuticals Inc.

NAS: ACAD

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205236646/composite

$

43.00

Change

+0.27 +0.63%

Volume

Volume 75,040

Aug 7, 2020, 6:43 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205236646/composite

Previous close

$ 43.63

$ 42.73

Change

-0.90 -2.06%

Day low

Day high

$42.68

$44.15

Open
Open: 43.99

52 week low

52 week high

$23.77

$58.72

Open

Market cap

$6.74B

Average volume

1.95M

P/E ratio

N/A

Rev. per Employee

$520,481

EPS

-1.47

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/acad

MarketWatch News on ACAD

  1. Charting a bull-trend whipsaw, S&P 500 nails next resistance

    12:35 p.m. July 14, 2020

    - Michael Ashbaugh

  2. Charting a bull-trend whipsaw, S&P 500 nails next resistance

    12:04 p.m. July 14, 2020

    - Michael Ashbaugh

  3. Acadia Pharmaceuticals upgraded to buy from hold at Stifel, price target raised to $71 from $41

    7:33 a.m. July 7, 2020

    - Tonya Garcia

  4. Don’t Expect Virgin Galactic Shares to Keep Rocketing Upward

    5:45 p.m. April 1, 2020

    - Barron's Online

  5. Wild Moves In Biotech Amid Deluge of Trial Data

    1:46 p.m. Dec. 5, 2019

    - Barron's Online

  6. Acadia Pharmaceuticals stock price target raised to $56 from $50 at SVB Leerink

    10:20 a.m. Dec. 5, 2019

    - Tomi Kilgore

  7. Beacon Roofing, Sunrun, Marchex, and Other 13D Filings

    3:35 p.m. Oct. 3, 2019

    - Barron's Online

  8. Acadia Pharmaceuticals upgraded to outperform from market perform at SVB Leerink

    7:10 a.m. Sept. 13, 2019

    - Tomi Kilgore

  9. Acadia Pharmaceuticals stock price target raised to $50 from $21 at SVB Leerink

    7:10 a.m. Sept. 13, 2019

    - Tomi Kilgore

  10. Acadia Pharmaceuticals upgraded to buy at Canaccord Genuity

    11:57 a.m. Sept. 10, 2019

    - Tomi Kilgore

  11. Acadia stock drops as schizophrenia drug doesn't pass clinical trial

    4:53 p.m. July 22, 2019

    - Wallace Witkowski

  12. U.S. Stocks Are Still Stuck Because Uncertainty Is Everywhere

    12:14 p.m. March 28, 2019

    - Barron's Online

  13. These are the stocks that options investors are most worried about

    7:53 a.m. Oct. 11, 2018

    - Ryan Vlastelica

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/acad

Other News on ACAD

  1. 10-Q: ACADIA PHARMACEUTICALS INC

    6:05 a.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  2. Aytu (AYTU) to Report Q4 Earnings: What's in the Cards?

    11:56 a.m. Aug. 4, 2020

    - Zacks.com

  3. Amneal (AMRX) to Report Q2 Earnings: What's in the Cards?

    12:08 p.m. Aug. 3, 2020

    - Zacks.com

  4. Zoetis (ZTS) to Report Q2 Earnings: What's in the Cards?

    12:03 p.m. Aug. 3, 2020

    - Zacks.com

  5. Nabriva (NBRV) to Report Q2 Earnings: What's in the Cards?

    10:21 a.m. July 29, 2020

    - Zacks.com

  6. ACADIA Pharmaceuticals (ACAD) Investor Presentation - Slideshow

    7:27 a.m. July 29, 2020

    - Seeking Alpha

  7. ACADIA (ACAD) to Report Q2 Earnings: What's in the Cards?

    11:33 a.m. July 28, 2020

    - Zacks.com

  8. ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from J.P. Morgan

    5:02 a.m. July 28, 2020

    - SmarterAnalyst

  9. Loading more headlines...
/news/pressrelease/company/us/acad

Press Releases on ACAD

  1. ACADIA Pharmaceuticals Reports Second Quarter 2020 Financial Results

    7:19 a.m. Aug. 6, 2020

    - BusinessWire - BZX

  2. Tuesday's ETF Movers: XOP, FBT

    12:01 p.m. July 21, 2020

    - MarketNewsVideo.com

  3. Tuesday Sector Laggards: Biotechnology, Drugs

    12:01 p.m. July 21, 2020

    - MarketNewsVideo.com

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.